Stocks
Edesa Biotech, Inc.EDSA
NASDAQHealthcareBiotechnology$2.78
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing monoclonal antibodies for inflammatory and infectious diseases, with lead candidates targeting acute respiratory distress syndrome and COVID-19. Its pipeline also includes treatments for dermatological conditions, and the stock is tracked by investors for its progress in Phase 2 and Phase 3 trials.
52W Range: $0.72-$20.32
Congressional Interest in Edesa Biotech, Inc. (EDSA)
No congressional trades have been disclosed for Edesa Biotech, Inc. (EDSA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading EDSA?
No congressional trades found for this stock.